Article
Integrative genomic analysis identifies clinically relevant prognostic markers for colorectal cancer patients with liver metastasis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Mar 2026
Li Wentao, Liu Ming, Wu Liula, Zhu Bosen, Li Xiangtao, Yang Ziyi, Liang Yi, Lin Junqiong
Abstract excerpt
PURPOSE: Colorectal liver metastases (CRLM) pose a significant clinical challenge due to their high recurrence rates, even after surgical resection. There is an urgent need for reliable prognostic biomarkers to improve risk stratification and guide treatment decisions for CRLM patients. METHODS/PATIENTS: In this study, we performed whole-exome sequencing (WES) on 57 CRLM patients and conducted a comparative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
